Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 2Tumor-Agnostic 1Gynecologic 1Gastrointestinal 1Classical hematology 1Breast 1

Conditions

Venous Thromboembolism 1Glioma 1Dyskinesias 1

Interventions

fludarabine phosphate 9Cyclophosphamide 8Cyclosporine 7Busulfan 6Antilymphocyte Serum 6fludarabine 5Melphalan 5Peripheral Blood Stem Cell Transplantation 4Mycophenolic Acid 4Rivaroxaban 3Radiotherapy 3Methylprednisolone 3Filgrastim 3Cord Blood Stem Cell Transplantation 3thymoglobulin 2ferric carboxymaltose 2apixaban 2Whole-Body Irradiation 2Therapeutics 2Methotrexate 2Heparin, Low-Molecular-Weight 2Hematologic Tests 2Genetic Counseling 2Fondaparinux 2Enoxaparin 2Educational Status 2Drug Therapy 2Dalteparin 2Cytarabine 2sulforaphane 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Long-Term Synaptic Depression × Classical hematology × Clear all
NCT06196918 2024-01-09

Efficacy and Safety of Rivaroxaban in the Prevention of Venous Thromboembolism in Glioma Patients

Nanfang Hospital, Southern Medical University

Phase NA Unknown
320 enrolled
CNSClassical hematology

Glioma, Dyskinesias, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡